| abstract |
Disclosed is a therapeutic agent for atypical mycobacteria such as mycobacteria, particularly an anti-tuberculosis therapeutic agent. (I) An antituberculous therapeutic drug containing an oxazole compound represented by the general formula (1) and a drug (II) such as a secondary antituberculous drug. [R 1 is H is a C 1-6 alkyl group; n is an integer of 0-6; R 2 is the following general formula (A), etc.] (R 3 represents a phenoxy group (on the phenyl ring, at least one group selected from the group consisting of a halogen atom, a halogen-substituted or unsubstituted C 1-6 alkyl group, and a halogen-substituted or unsubstituted C 1-6 alkoxy group) Seeds may be substituted) etc) [Selection figure] None |